M. Junttila
Molecular Biology · 2007–2019
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 83 citations into it
Whom M. Junttila trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- R. Davis
- Annapoorni Rangarajan
- Walter Kolch
- Lisa M. Coussens
- N. Ferrara
- Philippe P Roux
- C. Weston
- E. Shaulian
- M. McKay
- Sue-Jean Hong
Who trusts M. Junttila overall
Papers from M. Junttila's perspective
Ordered by how strongly the researchers M. Junttila trusts endorse each paper. Same corpus, a different order for every researcher.
- The RAF proteins take centre stage (Nature reviews. Molecular cell biology)
- Mutations of the BRAF gene in human cancer (Nature)
- Coordinating ERK/MAPK signalling through scaffolds and inhibitors (Nature reviews. Molecular cell biology)
- Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. (Biochemical Journal)
- Signal transduction by the JNK group of MAP kinases. (Cell)
- Regulation of Raf-1 by direct feedback phosphorylation. (Molecules and Cells)
- The JNK signal transduction pathway. (Current Opinion in Genetics and Development)
- Species- and cell type-specific requirements for cellular transformation. (Cancer Cell)
- Melanoma biology and new targeted therapy (Nature)
- Integrative genomic approaches identify IKBKE as a breast cancer oncogene. (Cell)
Their papers
- Influence of tumour micro-environment heterogeneity on therapeutic response (2013) — 2,517 citations
- Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival (2008) — 835 citations
- CIP2A inhibits PP2A in human malignancies. (2007) — 633 citations
- Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. (2019) — 641 citations